Objective. Untreated obstructive sleep apnea syndrome (OSAS) increases the risk of cardiovascular, dementia, and motor vehicle accident events. However, continuous positive airway pressure (CPAP) which is the gold standard treatment is not acceptable for many patients with OSAS. Development of devices for the patients of nonadherence to CPAP is necessary. Materials and Methods. We evaluated the effect of the smart antisnore pillow (SAP) in patients with OSAS in a prospective, noncontrolled, nonrandomized, pilot study. According to the apnea-hypopnea index (AHI), they were divided into two groups: mild-to-moderate OSAS group and severe OSAS group. Single-night polysomnography (PSG) with application of a SAP was performed. Thirty patients, 15 males and 15 females, 33–82 years old (mean age, years), completed the smart antisnore pillow therapy test. Among them, 23 patients had mild-to-moderate OSAS. Results. The SAP significantly improved the snore number (), snore index (), oxygen denaturation index (), total AHI (), and supine AHI () in the mild-to-moderate OSAS group, but there was no significant improvement in the severe OSAS group. Conclusions. We concluded that the SAP is an effective positional therapy device for patients with OSAS of mild-to-moderate severity.

中文翻译：

---

智能止鼾枕对阻塞性睡眠呼吸暂停综合征患者的疗效

客观。未经治疗的阻塞性睡眠呼吸暂停综合征 (OSAS) 会增加心血管、痴呆和机动车事故事件的风险。然而，作为金标准治疗的持续气道正压通气 (CPAP) 对于许多 OSAS 患者来说是不可接受的。有必要为不依从 CPAP 的患者开发设备。材料和方法。我们在一项前瞻性、非对照、非随机的试点研究中评估了智能止鼾枕 (SAP) 在 OSAS 患者中的作用。根据呼吸暂停-低通气指数（AHI）分为两组：轻中度OSAS组和重度OSAS组。进行了应用 SAP 的单夜多导睡眠图 (PSG)。患者 30 例，男 15 例，女 15 例，年龄 33～82 岁（平均年龄，年），完成了智能止鼾枕疗法测试。其中，23例患者有轻中度OSAS。结果。SAP 显着改善了打鼾次数（),打鼾指数 (),氧变性指数 (),总 AHI ()和仰卧 AHI ()在轻度至中度 OSAS 组中，但在重度 OSAS 组中没有明显改善。结论。我们得出结论，SAP 是一种有效的体位治疗设备，适用于轻度至中度严重 OSAS 患者。